LISBURN PHARMA LIMITED - Profile & Financials

Accounts Submitted 16 Jul 2025

Confirmation Statement Submitted 2 Oct 2025

Net assets £-49.25K £11.54K 2024 year on year

Total assets £117.09K £4.92K 2024 year on year

Total Liabilities £166.35K £16.47K 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Carnbane House Shepherds Way Carnbane Industrial Estate Newry BT35 6EE United Kingdom

Credit Report

Discover LISBURN PHARMA LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£19.76k

Increased by £5.02k (+34%)

Net Assets

-£49.25k

Decreased by £11.54k (-31%)

Total Liabilities

£166.35k

Increased by £16.47k (+11%)

Turnover

N/A

Employees

N/A

Debt Ratio

142%

Increased by 8 (+6%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active 5 resigned

Show resigned officers

						Status
Cathal Edward James O'hare	Director	Northern Irish	Northern Ireland	47	28 May 2025	Active
Christine Phillips	Director	British	England	43	10 Jul 2024	Active
Kevin Stuart Hawkins	Director	British	United Kingdom	56	26 Apr 2023	Active
Tyrone James Allard	Director	Irish	Northern Ireland	65	31 Jan 2024	Active

Shareholders

Shareholders (2)


Kajima Partnerships Limited	50.0%	2	Ordinary	2 Oct 2025
Carnbane Health Limited	50.0%	2	Ordinary	2 Oct 2025

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Kajima Partnerships Limited

United Kingdom

Active

Notified 10 Aug 2018

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Right To Appoint And Remove Directors As Firm
Significant Influence Or Control As Firm

Carnbane Health Limited

United Kingdom

Active

Notified 10 Aug 2018

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Right To Appoint And Remove Directors As Firm
Significant Influence Or Control As Firm

See All Controllers

Group Structure

KAJIMA PARTNERSHIPS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

CARNBANE HEALTH LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

CARNBANE ESTATES LIMITED united kingdom

KAJIMA ESTATES (EUROPE) LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

KAJIMA EUROPE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

KAJIMA CORPORATION japan

LISBURN PHARMA LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
2 Oct 2025	Confirmation Statement	Confirmation statement made on 2025-08-09 with updates	View(5 pages)
16 Jul 2025	Accounts	Annual accounts made up to 2024-12-31	View(12 pages)
17 Jun 2025	Officers	Appointment of Mr Cathal Edward James O'hare as director on 2025-05-28	View(2 pages)
1 Nov 2024	Officers	Termination of Eamon O'hare as director on 2024-10-24	View(1 page)
5 Sept 2024	Accounts	Annual accounts made up to 2023-12-31	View(12 pages)